| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depressive Disorder, Major | 19 | 2024 | 125 | 2.650 |
Why?
|
| T-Lymphocytes | 18 | 2011 | 279 | 1.750 |
Why?
|
| Thymus Gland | 7 | 2011 | 53 | 1.660 |
Why?
|
| Brain Concussion | 10 | 2021 | 43 | 1.460 |
Why?
|
| Kynurenine | 13 | 2022 | 21 | 1.400 |
Why?
|
| Kynurenic Acid | 11 | 2022 | 18 | 1.330 |
Why?
|
| Athletic Injuries | 9 | 2021 | 116 | 1.260 |
Why?
|
| Interleukin-7 | 4 | 2015 | 10 | 1.090 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2020 | 56 | 1.050 |
Why?
|
| Quinolinic Acid | 12 | 2022 | 18 | 1.000 |
Why?
|
| Lymphocyte Activation | 14 | 2004 | 205 | 1.000 |
Why?
|
| Stress, Psychological | 3 | 2021 | 211 | 0.930 |
Why?
|
| Football | 8 | 2021 | 68 | 0.920 |
Why?
|
| Cytomegalovirus Infections | 5 | 2024 | 36 | 0.900 |
Why?
|
| Cell Differentiation | 7 | 2015 | 398 | 0.890 |
Why?
|
| Precursor Cells, T-Lymphoid | 2 | 2015 | 7 | 0.830 |
Why?
|
| Oxidative Stress | 2 | 2021 | 635 | 0.760 |
Why?
|
| Sirtuin 1 | 1 | 2021 | 40 | 0.740 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 305 | 0.640 |
Why?
|
| Signal Transduction | 13 | 2024 | 1379 | 0.630 |
Why?
|
| Bipolar Disorder | 5 | 2018 | 39 | 0.590 |
Why?
|
| Lymphopoiesis | 2 | 2015 | 22 | 0.560 |
Why?
|
| Inflammation | 8 | 2022 | 608 | 0.560 |
Why?
|
| C-Reactive Protein | 10 | 2023 | 93 | 0.540 |
Why?
|
| Humans | 57 | 2024 | 27119 | 0.520 |
Why?
|
| Trans-Activators | 4 | 2004 | 114 | 0.510 |
Why?
|
| Female | 36 | 2024 | 14635 | 0.510 |
Why?
|
| Cells, Cultured | 10 | 2015 | 976 | 0.500 |
Why?
|
| Interleukin-18 | 1 | 2015 | 16 | 0.490 |
Why?
|
| Receptors, Interleukin-7 | 3 | 2010 | 8 | 0.490 |
Why?
|
| Appetite | 3 | 2019 | 19 | 0.490 |
Why?
|
| Mice | 19 | 2021 | 4473 | 0.490 |
Why?
|
| Hippocampus | 5 | 2020 | 186 | 0.470 |
Why?
|
| Cytokines | 5 | 2021 | 440 | 0.470 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 5 | 2010 | 68 | 0.460 |
Why?
|
| Interleukin-6 | 6 | 2019 | 189 | 0.450 |
Why?
|
| Adult | 23 | 2024 | 7492 | 0.440 |
Why?
|
| Male | 31 | 2024 | 13022 | 0.440 |
Why?
|
| Ibuprofen | 3 | 2022 | 17 | 0.430 |
Why?
|
| Mice, Inbred C57BL | 13 | 2011 | 1496 | 0.420 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2024 | 811 | 0.410 |
Why?
|
| Animals | 21 | 2021 | 10080 | 0.400 |
Why?
|
| Reward | 3 | 2023 | 45 | 0.400 |
Why?
|
| Extracellular Vesicles | 2 | 2024 | 36 | 0.400 |
Why?
|
| CD28 Antigens | 2 | 2010 | 11 | 0.400 |
Why?
|
| Interoception | 2 | 2024 | 21 | 0.390 |
Why?
|
| White Matter | 3 | 2022 | 89 | 0.390 |
Why?
|
| Cell Proliferation | 1 | 2015 | 774 | 0.380 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 481 | 0.380 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2011 | 2 | 0.380 |
Why?
|
| Interleukin-6 Receptor alpha Subunit | 1 | 2011 | 2 | 0.380 |
Why?
|
| Integrins | 6 | 1999 | 27 | 0.360 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2010 | 2 | 0.340 |
Why?
|
| Young Adult | 15 | 2023 | 2626 | 0.330 |
Why?
|
| Depression | 4 | 2019 | 212 | 0.320 |
Why?
|
| Brain | 5 | 2024 | 710 | 0.310 |
Why?
|
| Sialyltransferases | 1 | 2008 | 5 | 0.310 |
Why?
|
| Memory, Episodic | 2 | 2020 | 18 | 0.310 |
Why?
|
| Interleukin-7 Receptor alpha Subunit | 1 | 2008 | 5 | 0.300 |
Why?
|
| Middle Aged | 14 | 2024 | 6900 | 0.300 |
Why?
|
| Flow Cytometry | 5 | 2011 | 285 | 0.300 |
Why?
|
| RNA, Messenger | 5 | 2018 | 648 | 0.300 |
Why?
|
| Hepatocytes | 1 | 2007 | 75 | 0.280 |
Why?
|
| Adolescent | 8 | 2023 | 2988 | 0.280 |
Why?
|
| Oxygen | 1 | 2007 | 230 | 0.270 |
Why?
|
| Cell Survival | 6 | 2008 | 395 | 0.260 |
Why?
|
| Erythrocyte Transfusion | 1 | 2006 | 15 | 0.260 |
Why?
|
| Capillary Permeability | 1 | 2006 | 38 | 0.260 |
Why?
|
| Athletes | 7 | 2020 | 70 | 0.250 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 190 | 0.240 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2024 | 18 | 0.240 |
Why?
|
| Biomarkers | 4 | 2022 | 738 | 0.230 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 626 | 0.230 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 2004 | 2 | 0.230 |
Why?
|
| Milk Proteins | 1 | 2004 | 18 | 0.230 |
Why?
|
| Phosphorylation | 4 | 2011 | 567 | 0.230 |
Why?
|
| Gene Expression Profiling | 5 | 2015 | 440 | 0.220 |
Why?
|
| Amygdala | 2 | 2014 | 52 | 0.220 |
Why?
|
| NF-kappa B | 1 | 2024 | 187 | 0.220 |
Why?
|
| Interferons | 1 | 2004 | 68 | 0.220 |
Why?
|
| Insulins | 1 | 2023 | 6 | 0.220 |
Why?
|
| Motivation | 2 | 2023 | 210 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2006 | 331 | 0.210 |
Why?
|
| Repressor Proteins | 2 | 2004 | 114 | 0.210 |
Why?
|
| MicroRNAs | 2 | 2024 | 281 | 0.210 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 17 | 0.200 |
Why?
|
| Mental Processes | 1 | 2022 | 16 | 0.200 |
Why?
|
| Healthy Volunteers | 1 | 2022 | 48 | 0.190 |
Why?
|
| STAT1 Transcription Factor | 3 | 2011 | 37 | 0.190 |
Why?
|
| Neural Pathways | 2 | 2019 | 118 | 0.190 |
Why?
|
| PPAR gamma | 1 | 2021 | 29 | 0.190 |
Why?
|
| Mindfulness | 1 | 2021 | 8 | 0.180 |
Why?
|
| Blood Alcohol Content | 1 | 2021 | 5 | 0.180 |
Why?
|
| Antigens, CD | 4 | 2010 | 134 | 0.180 |
Why?
|
| Transcription Factor AP-1 | 1 | 2000 | 26 | 0.170 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2011 | 121 | 0.170 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 162 | 0.160 |
Why?
|
| Cell Separation | 3 | 2011 | 55 | 0.160 |
Why?
|
| Corpus Striatum | 2 | 2017 | 22 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 353 | 0.160 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 3 | 2004 | 9 | 0.160 |
Why?
|
| Cerebral Cortex | 2 | 2016 | 134 | 0.150 |
Why?
|
| Photochemotherapy | 2 | 2010 | 40 | 0.150 |
Why?
|
| Measles Vaccine | 1 | 2018 | 2 | 0.150 |
Why?
|
| Measles | 1 | 2018 | 3 | 0.150 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 76 | 0.150 |
Why?
|
| Minocycline | 1 | 2018 | 7 | 0.150 |
Why?
|
| Diet | 1 | 2019 | 226 | 0.150 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 29 | 0.150 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2017 | 9 | 0.150 |
Why?
|
| STAT5 Transcription Factor | 2 | 2010 | 6 | 0.140 |
Why?
|
| Skin Neoplasms | 2 | 2010 | 118 | 0.140 |
Why?
|
| Kynurenine 3-Monooxygenase | 1 | 2017 | 1 | 0.140 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2017 | 2 | 0.140 |
Why?
|
| Melanoma | 2 | 2010 | 128 | 0.140 |
Why?
|
| Apoptosis | 2 | 1999 | 740 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2000 | 247 | 0.140 |
Why?
|
| Aspirin | 1 | 2018 | 122 | 0.140 |
Why?
|
| Case-Control Studies | 4 | 2024 | 705 | 0.130 |
Why?
|
| Cell Death | 4 | 2007 | 111 | 0.130 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 46 | 0.130 |
Why?
|
| Sleep Wake Disorders | 1 | 2017 | 65 | 0.130 |
Why?
|
| Sex Characteristics | 1 | 2017 | 163 | 0.130 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2016 | 1 | 0.130 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2016 | 3 | 0.130 |
Why?
|
| Dentate Gyrus | 1 | 2016 | 9 | 0.130 |
Why?
|
| Mental Recall | 1 | 2016 | 45 | 0.130 |
Why?
|
| Connectome | 1 | 2016 | 87 | 0.130 |
Why?
|
| Post-Concussion Syndrome | 1 | 2015 | 4 | 0.130 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2022 | 79 | 0.130 |
Why?
|
| Mood Disorders | 1 | 2015 | 24 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2015 | 10 | 0.120 |
Why?
|
| Prefrontal Cortex | 1 | 2015 | 79 | 0.120 |
Why?
|
| CD4 Antigens | 2 | 2010 | 18 | 0.120 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 58 | 0.120 |
Why?
|
| Community Medicine | 1 | 2014 | 9 | 0.120 |
Why?
|
| Schools, Medical | 1 | 2014 | 45 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2014 | 51 | 0.120 |
Why?
|
| Aged | 3 | 2021 | 5222 | 0.110 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 51 | 0.110 |
Why?
|
| Photomicrography | 1 | 1993 | 2 | 0.110 |
Why?
|
| Videotape Recording | 1 | 1993 | 8 | 0.110 |
Why?
|
| Dose-Response Relationship, Immunologic | 3 | 2004 | 13 | 0.110 |
Why?
|
| Cross-Sectional Studies | 4 | 2019 | 928 | 0.110 |
Why?
|
| Immunologic Memory | 2 | 2006 | 58 | 0.110 |
Why?
|
| Students, Medical | 1 | 2014 | 95 | 0.110 |
Why?
|
| Infrared Rays | 2 | 2010 | 23 | 0.110 |
Why?
|
| Logistic Models | 3 | 2019 | 398 | 0.110 |
Why?
|
| Gray Matter | 3 | 2020 | 23 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2008 | 489 | 0.100 |
Why?
|
| Prospective Studies | 3 | 2021 | 1219 | 0.100 |
Why?
|
| Cytomegalovirus | 2 | 2024 | 22 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2018 | 93 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 2 | 2004 | 3 | 0.100 |
Why?
|
| Down-Regulation | 2 | 2004 | 198 | 0.100 |
Why?
|
| Interferon-gamma | 2 | 2019 | 103 | 0.090 |
Why?
|
| CD3 Complex | 3 | 2004 | 23 | 0.090 |
Why?
|
| Cell Lineage | 1 | 2011 | 45 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2002 | 139 | 0.090 |
Why?
|
| Universities | 3 | 2016 | 115 | 0.090 |
Why?
|
| Leptin | 2 | 2023 | 67 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 5 | 1996 | 318 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 2004 | 246 | 0.090 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2010 | 10 | 0.090 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2010 | 19 | 0.090 |
Why?
|
| CD8 Antigens | 1 | 2010 | 10 | 0.090 |
Why?
|
| Coculture Techniques | 1 | 2010 | 54 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2010 | 36 | 0.080 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 79 | 0.080 |
Why?
|
| Cell Division | 4 | 2003 | 153 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 325 | 0.080 |
Why?
|
| Immunotherapy | 1 | 2010 | 141 | 0.080 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2019 | 10 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2020 | 102 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2022 | 405 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 237 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2022 | 589 | 0.080 |
Why?
|
| Cell Count | 1 | 2008 | 85 | 0.080 |
Why?
|
| Oligosaccharides | 1 | 2008 | 33 | 0.070 |
Why?
|
| DNA, Complementary | 1 | 2008 | 76 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2007 | 22 | 0.070 |
Why?
|
| Laminin | 1 | 2007 | 21 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2007 | 31 | 0.070 |
Why?
|
| Proteoglycans | 1 | 2007 | 37 | 0.070 |
Why?
|
| Drug Combinations | 1 | 2007 | 50 | 0.070 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 35 | 0.070 |
Why?
|
| Interview, Psychological | 2 | 2019 | 12 | 0.070 |
Why?
|
| Gene Transfer Techniques | 1 | 2008 | 66 | 0.070 |
Why?
|
| Prognosis | 2 | 2020 | 763 | 0.070 |
Why?
|
| Models, Animal | 1 | 2007 | 129 | 0.070 |
Why?
|
| Aminoquinolines | 1 | 2006 | 11 | 0.070 |
Why?
|
| Integrin beta1 | 3 | 1996 | 15 | 0.070 |
Why?
|
| Collagen | 1 | 2007 | 147 | 0.070 |
Why?
|
| STAT Transcription Factors | 1 | 2006 | 2 | 0.070 |
Why?
|
| Receptors, Cytokine | 1 | 2006 | 5 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2006 | 22 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2010 | 846 | 0.070 |
Why?
|
| Interleukin-2 | 3 | 1996 | 33 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2007 | 236 | 0.070 |
Why?
|
| Infant | 1 | 2010 | 966 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 546 | 0.070 |
Why?
|
| Child, Preschool | 1 | 2010 | 1100 | 0.070 |
Why?
|
| Electric Impedance | 1 | 2006 | 30 | 0.070 |
Why?
|
| Cell Adhesion | 5 | 2003 | 133 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2021 | 2283 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2008 | 794 | 0.060 |
Why?
|
| Transcription Factors | 3 | 2004 | 512 | 0.060 |
Why?
|
| Anhedonia | 2 | 2015 | 4 | 0.060 |
Why?
|
| Kinetics | 3 | 1995 | 538 | 0.060 |
Why?
|
| Tryptophan | 2 | 2015 | 39 | 0.060 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2024 | 1 | 0.060 |
Why?
|
| Organ Size | 2 | 2015 | 85 | 0.060 |
Why?
|
| Adjuvants, Immunologic | 2 | 2002 | 63 | 0.060 |
Why?
|
| Interferon Regulatory Factors | 1 | 2024 | 57 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2004 | 4 | 0.060 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2004 | 6 | 0.060 |
Why?
|
| Rats | 1 | 2007 | 1554 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 1994 | 239 | 0.060 |
Why?
|
| Receptors, Interferon | 1 | 2004 | 12 | 0.060 |
Why?
|
| Enterotoxins | 1 | 2004 | 21 | 0.060 |
Why?
|
| Interferon-alpha | 1 | 2004 | 50 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 95 | 0.050 |
Why?
|
| Adiponectin | 1 | 2023 | 29 | 0.050 |
Why?
|
| Antibodies | 1 | 2004 | 124 | 0.050 |
Why?
|
| Students | 2 | 2016 | 190 | 0.050 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2003 | 10 | 0.050 |
Why?
|
| Endothelin-1 | 1 | 2023 | 10 | 0.050 |
Why?
|
| Genes, bcl-2 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2004 | 241 | 0.050 |
Why?
|
| Mice, Inbred BALB C | 2 | 2001 | 264 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2022 | 132 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 400 | 0.050 |
Why?
|
| Demography | 1 | 2022 | 91 | 0.050 |
Why?
|
| Placebo Effect | 1 | 2022 | 6 | 0.050 |
Why?
|
| Neurons | 1 | 2024 | 276 | 0.050 |
Why?
|
| DNA | 2 | 1994 | 365 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2022 | 59 | 0.050 |
Why?
|
| Proteins | 1 | 2004 | 245 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2023 | 351 | 0.050 |
Why?
|
| Glucuronates | 1 | 2021 | 3 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2019 | 243 | 0.050 |
Why?
|
| Cyclooxygenase 2 | 1 | 2021 | 68 | 0.050 |
Why?
|
| Anisotropy | 1 | 2021 | 19 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2006 | 658 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2022 | 397 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2020 | 31 | 0.040 |
Why?
|
| Psychometrics | 1 | 2021 | 117 | 0.040 |
Why?
|
| Self Report | 1 | 2021 | 116 | 0.040 |
Why?
|
| Interphase | 1 | 2000 | 6 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2021 | 191 | 0.040 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2000 | 11 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 408 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2000 | 59 | 0.040 |
Why?
|
| Genome | 1 | 2000 | 52 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 139 | 0.040 |
Why?
|
| Schools | 1 | 2020 | 71 | 0.040 |
Why?
|
| Pleasure | 1 | 2019 | 8 | 0.040 |
Why?
|
| Emotions | 1 | 2021 | 131 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1999 | 74 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2020 | 117 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 189 | 0.040 |
Why?
|
| STAT3 Transcription Factor | 1 | 2000 | 92 | 0.040 |
Why?
|
| Cell Size | 2 | 2003 | 22 | 0.040 |
Why?
|
| Food | 1 | 2019 | 31 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 92 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 58 | 0.040 |
Why?
|
| Adult Survivors of Child Adverse Events | 1 | 2019 | 8 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1999 | 75 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2019 | 42 | 0.040 |
Why?
|
| Type C Phospholipases | 1 | 1999 | 31 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2019 | 49 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2019 | 68 | 0.040 |
Why?
|
| Laser Therapy | 2 | 2010 | 30 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2019 | 112 | 0.040 |
Why?
|
| Ghrelin | 1 | 2018 | 7 | 0.040 |
Why?
|
| Exercise | 1 | 2023 | 469 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2018 | 119 | 0.040 |
Why?
|
| Remission Induction | 1 | 2018 | 50 | 0.040 |
Why?
|
| Age of Onset | 1 | 2018 | 68 | 0.040 |
Why?
|
| Fibronectins | 4 | 2003 | 28 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 290 | 0.040 |
Why?
|
| Saliva | 1 | 2018 | 94 | 0.040 |
Why?
|
| Brain Mapping | 1 | 2019 | 199 | 0.040 |
Why?
|
| Integrin alpha4beta1 | 2 | 1995 | 4 | 0.040 |
Why?
|
| Hydrocortisone | 1 | 2018 | 88 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 74 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 1997 | 23 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 1999 | 280 | 0.040 |
Why?
|
| GABAergic Neurons | 1 | 2017 | 3 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2017 | 15 | 0.040 |
Why?
|
| Mice, Inbred Strains | 1 | 1997 | 61 | 0.040 |
Why?
|
| Base Sequence | 1 | 2018 | 573 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 204 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2018 | 229 | 0.040 |
Why?
|
| Psychotic Disorders | 1 | 2017 | 17 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2017 | 45 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 445 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 1996 | 2 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2018 | 172 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 1999 | 508 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 315 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 267 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1997 | 408 | 0.030 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2015 | 2 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 3 | 2003 | 310 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2015 | 21 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2015 | 77 | 0.030 |
Why?
|
| Affect | 1 | 2015 | 82 | 0.030 |
Why?
|
| Pseudopodia | 1 | 1995 | 7 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 930 | 0.030 |
Why?
|
| Reference Values | 1 | 2015 | 199 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 1994 | 7 | 0.030 |
Why?
|
| Organizational Innovation | 1 | 2014 | 19 | 0.030 |
Why?
|
| Organizational Culture | 1 | 2014 | 24 | 0.030 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 75 | 0.030 |
Why?
|
| Lymphocytes | 1 | 1995 | 82 | 0.030 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 22 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 404 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 113 | 0.030 |
Why?
|
| Reaction Time | 1 | 2014 | 94 | 0.030 |
Why?
|
| Analog-Digital Conversion | 1 | 1993 | 2 | 0.030 |
Why?
|
| Propidium | 1 | 1993 | 2 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 2030 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 139 | 0.030 |
Why?
|
| DNA Replication | 1 | 1993 | 49 | 0.030 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1992 | 1 | 0.030 |
Why?
|
| Integrin alpha Chains | 1 | 1992 | 4 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 988 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1993 | 163 | 0.030 |
Why?
|
| Curriculum | 1 | 2014 | 271 | 0.030 |
Why?
|
| Software | 1 | 1993 | 121 | 0.030 |
Why?
|
| Superantigens | 2 | 2002 | 6 | 0.020 |
Why?
|
| Oklahoma | 1 | 2014 | 978 | 0.020 |
Why?
|
| Cognition | 1 | 2014 | 298 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 2002 | 156 | 0.020 |
Why?
|
| Jurkat Cells | 2 | 2000 | 29 | 0.020 |
Why?
|
| Microscopy, Video | 2 | 2003 | 18 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 462 | 0.020 |
Why?
|
| Photosensitizing Agents | 1 | 2006 | 33 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 1940 | 0.020 |
Why?
|
| Cell Line | 2 | 2000 | 681 | 0.020 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2003 | 3 | 0.010 |
Why?
|
| ADP Ribose Transferases | 1 | 2003 | 4 | 0.010 |
Why?
|
| Cell Surface Extensions | 1 | 2003 | 5 | 0.010 |
Why?
|
| Botulinum Toxins | 1 | 2003 | 10 | 0.010 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2003 | 18 | 0.010 |
Why?
|
| Models, Immunological | 1 | 2002 | 22 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 340 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2002 | 34 | 0.010 |
Why?
|
| Actins | 1 | 2003 | 94 | 0.010 |
Why?
|
| Vaccinia virus | 1 | 2001 | 6 | 0.010 |
Why?
|
| Antioxidants | 1 | 2002 | 220 | 0.010 |
Why?
|
| Phorbol Esters | 1 | 2000 | 5 | 0.010 |
Why?
|
| Expressed Sequence Tags | 1 | 2000 | 8 | 0.010 |
Why?
|
| Microcomputers | 1 | 2000 | 4 | 0.010 |
Why?
|
| Video Recording | 1 | 2000 | 38 | 0.010 |
Why?
|
| Hybridomas | 1 | 1999 | 17 | 0.010 |
Why?
|
| Immunization, Secondary | 1 | 1999 | 10 | 0.010 |
Why?
|
| Microscopy | 1 | 2000 | 38 | 0.010 |
Why?
|
| Leukemia L1210 | 1 | 1999 | 2 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2000 | 84 | 0.010 |
Why?
|
| Hyaluronan Receptors | 1 | 1999 | 30 | 0.010 |
Why?
|
| fas Receptor | 1 | 1999 | 19 | 0.010 |
Why?
|
| Manganese | 1 | 1999 | 22 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 23 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 1999 | 61 | 0.010 |
Why?
|
| Caspases | 1 | 1999 | 43 | 0.010 |
Why?
|
| Metalloporphyrins | 1 | 1999 | 18 | 0.010 |
Why?
|
| Norbornanes | 1 | 1999 | 1 | 0.010 |
Why?
|
| Leukemia, T-Cell | 1 | 1999 | 2 | 0.010 |
Why?
|
| Benzophenanthridines | 1 | 1999 | 8 | 0.010 |
Why?
|
| Alkaloids | 1 | 1999 | 16 | 0.010 |
Why?
|
| Neomycin | 1 | 1999 | 7 | 0.010 |
Why?
|
| Phenanthridines | 1 | 1999 | 12 | 0.010 |
Why?
|
| Thiocarbamates | 1 | 1999 | 6 | 0.010 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 1999 | 12 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1999 | 13 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 1037 | 0.010 |
Why?
|
| Bridged-Ring Compounds | 1 | 1999 | 18 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2000 | 251 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1999 | 72 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 264 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1999 | 150 | 0.010 |
Why?
|
| Thiones | 1 | 1999 | 55 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 1999 | 247 | 0.010 |
Why?
|
| STAT6 Transcription Factor | 1 | 1997 | 2 | 0.010 |
Why?
|
| Integrin alpha4 | 1 | 1996 | 2 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 1996 | 14 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 62 | 0.010 |
Why?
|
| Mitochondria | 1 | 1999 | 342 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1996 | 114 | 0.010 |
Why?
|
| Epitopes | 1 | 1996 | 181 | 0.010 |
Why?
|
| Phospholipases A | 1 | 1995 | 6 | 0.010 |
Why?
|
| Lipoxygenase Inhibitors | 1 | 1995 | 16 | 0.010 |
Why?
|
| Phospholipases A2 | 1 | 1995 | 9 | 0.010 |
Why?
|
| Arachidonic Acid | 1 | 1995 | 18 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1995 | 25 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1995 | 143 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 52 | 0.010 |
Why?
|